Raw material sourcing meets cGMP testing, distribution

SAFC, the custom manufacturing and services group within Sigma-Aldrich, is partnering with Cherokee Pharmaceuticals in a deal that encompasses the sourcing, analytical testing, warehousing, packaging and distribution of large-scale raw materials for pharmaceutical manufacturing meeting cGMP quality standards.

SAFC president Gilles Cottier said in an announcement, "In marrying SAFC's sourcing capabilities with Cherokee Pharmaceuticals expertise in analytical testing and cGMP manufacture and storage, we are providing resourcing that will support our U.S. customers throughout their respective supply chains, enabling them to both streamline and improve their risk mitigation strategies."

The deal calls for SAFC to be responsible for product sourcing, including processing reagents and excipients, from its network of 10,000 active suppliers, while Cherokee will conduct analytical testing, storage, packaging and distribution services.

Cherokee's storage and expansion capabilities include its own dedicated rail link to the northeast U.S. corridor, home to many pharmaceutical companies. SAFC will use Cherokee's cGMP validated site, which can house cooled, frozen and hazardous substances and serve as a key East Coast analytical, warehousing and distribution hub for large-scale pharmaceutical raw materials.

- read the announcement

Suggested Articles

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

Boehringer Ingelheim is investing $50 million in an animal health plant in Puerto Rico, adding 105 jobs.

Teva will begin producing chemo drug vincristine in the U.S. but has resisted the idea that its withdrawal from the market led to a shortage.